These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 17433666)
1. Primary central nervous system lymphoma: biological aspects and controversies in management. Bessell EM; Hoang-Xuan K; Ferreri AJ; Reni M Eur J Cancer; 2007 May; 43(7):1141-52. PubMed ID: 17433666 [TBL] [Abstract][Full Text] [Related]
2. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma. Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853 [TBL] [Abstract][Full Text] [Related]
3. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma. Cheng T; Forsyth P; Chaudhry A; Morris D; Glück S; Russell JA; Stewart DA Bone Marrow Transplant; 2003 Apr; 31(8):679-85. PubMed ID: 12692608 [TBL] [Abstract][Full Text] [Related]
4. High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system. Illerhaus G; Müller F; Feuerhake F; Schäfer AO; Ostertag C; Finke J Haematologica; 2008 Jan; 93(1):147-8. PubMed ID: 18166803 [TBL] [Abstract][Full Text] [Related]
5. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy. Dabaja BS; McLaughlin P; Ha CS; Pro B; Meyers CA; Seabrooke LF; Wilder RB; Kyritsis AP; Preti HA; Yung WK; Levin V; Cabanillas F; Cox JD Cancer; 2003 Sep; 98(5):1021-8. PubMed ID: 12942571 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of primary central nervous system lymphoma in the immunocompetent patient]. Sierra Del Rio M; Benouaich-Amiel A; Psimaras D; Dehais C; Hoang-Xuan K Rev Neurol (Paris); 2008; 164(6-7):569-74. PubMed ID: 18565356 [TBL] [Abstract][Full Text] [Related]
7. Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma. Korfel A; Thiel E; Martus P; Möhle R; Griesinger F; Rauch M; Röth A; Hertenstein B; Fischer T; Hundsberger T; Mergenthaler HG; Junghanß C; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Roth P; Bamberg M; Pietsch T; Weller M Neurology; 2015 Mar; 84(12):1242-8. PubMed ID: 25716362 [TBL] [Abstract][Full Text] [Related]
8. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. Poortmans PM; Kluin-Nelemans HC; Haaxma-Reiche H; Van't Veer M; Hansen M; Soubeyran P; Taphoorn M; Thomas J; Van den Bent M; Fickers M; Van Imhoff G; Rozewicz C; Teodorovic I; van Glabbeke M; J Clin Oncol; 2003 Dec; 21(24):4483-8. PubMed ID: 14597741 [TBL] [Abstract][Full Text] [Related]
10. Current management of primary central nervous system lymphoma. Schultz CJ; Bovi J Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):666-78. PubMed ID: 20159361 [TBL] [Abstract][Full Text] [Related]
11. Treatment options for central nervous system lymphomas in immunocompetent patients. Jahnke K; Thiel E Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839 [TBL] [Abstract][Full Text] [Related]
12. A focus on pharmacotherapy for primary central nervous system lymphoma. Korfel A Expert Rev Hematol; 2015 Oct; 8(5):559-62. PubMed ID: 26159859 [TBL] [Abstract][Full Text] [Related]
13. Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51. Laack NN; Ballman KV; Brown PB; O'Neill BP; Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1429-39. PubMed ID: 16863926 [TBL] [Abstract][Full Text] [Related]
14. Results of treatment of 112 cases of primary CNS lymphoma. Yamanaka R; Morii K; Shinbo Y; Homma J; Sano M; Tsuchiya N; Yajima N; Tamura T; Hondoh H; Takahashi H; Kakuma T; Tanaka R Jpn J Clin Oncol; 2008 May; 38(5):373-80. PubMed ID: 18413337 [TBL] [Abstract][Full Text] [Related]
15. Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up. Omuro AM; DeAngelis LM; Yahalom J; Abrey LE Neurology; 2005 Jan; 64(1):69-74. PubMed ID: 15642906 [TBL] [Abstract][Full Text] [Related]
16. MATILDE chemotherapy regimen for primary CNS lymphoma: results at a median follow-up of 12 years. Ferreri AJ; Ciceri F; Brandes AA; Montanari M; Balzarotti M; Spina M; Ilariucci F; Zaja F; Stelitano C; Bobbio F; Corazzelli G; Baldini L; Reni M Neurology; 2014 Apr; 82(15):1370-3. PubMed ID: 24634458 [TBL] [Abstract][Full Text] [Related]
17. [Primary central nervous system lymphoma--a report of 32 cases with literature review]. Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684 [TBL] [Abstract][Full Text] [Related]
18. Preliminary results of combined chemotherapy and radiotherapy for non-AIDS primary central nervous system lymphoma. Trans-Tasman Radiation Oncology Group (TROG). O'Brien PC; Roos DE; Liew KH; Trotter GE; Barton MB; Walker QJ; Poulsen MG; Olver IN Med J Aust; 1996 Oct; 165(8):424-7. PubMed ID: 8913243 [TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience. Ney DE; Reiner AS; Panageas KS; Brown HS; DeAngelis LM; Abrey LE Cancer; 2010 Oct; 116(19):4605-12. PubMed ID: 20572045 [TBL] [Abstract][Full Text] [Related]
20. The role of radiation therapy in the management of primary central nervous system lymphoma. Milgrom SA; Yahalom J Leuk Lymphoma; 2015 May; 56(5):1197-204. PubMed ID: 25219590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]